The europe dna synthesis market size surpassed USD 1.05 billion in 2025 and is predicted to reach around USD 4.63 billion by 2035, registering a CAGR of 16% from 2026 to 2035.Growing due to strong biotech research and high funding.

Europe DNA Synthesis Market Statical Scope

Market trends are being shaped by an increasing emphasis on bio-based and sustainable production. Demand for DNA synthesis is being driven by the growth of research and academic institutions. Innovation pathways are being influenced by the regulatory focus on ethical genetic engineering. Advanced genomics research is supported by increased investments in precision medicine.

Europe DNA Synthesis Market, By Service Type, 2025 (%)

• Oligonucleotide synthesis- Oligonucleotide synthesis leads the market with a share of 68.00% driven by high demand for custom primers and probes in clinical and research workflows.
• Gene Synthesis- Gene synthesis accounts for a significant portion with a market share of 32.00% driven by advancements in synthetic biology and DNA engineering technologies

Europe DNA Synthesis Market, By Application, 2025 (%)

• Research and Development- Research and development leads the market with a share of 45% driven by continuous innovation in biotechnology and pharmaceutical sectors.
• Diagnostics- Diagnostics account for a significant share, representing 27% of market share, driven by rapid adoption of genetic testing and early disease detection solutions.
• Therapeutics- Therapeutics represents a notable segment capturing a share of 28% driven by increasing focus on RNA-based drugs and gene therapies.

Europe DNA Synthesis Market, By End Use, 2025 (%)

• Biopharmaceutical & Diagnostics Companies- Biopharmaceutical & diagnostic companies lead the market with 42% market share driven by increasing investments in biologics and nucleic acid-based drugs.
• Academic & Research Institutes- Academic & research institutes account for a significant portion, representing a share of 38% driven by collaborative research programs and government funding support.
• Contract Research Organizations- Contract research organizations hold a notable segment capturing a share of 20% driven by cost efficiency and scalability benefits offered to pharma companies.

Top Companies in the Europe DNA Synthesis Market

• Thermo Fisher Scientific, Inc
• Twist Bioscience
• BIONEER CORPORATION
• Eton Bioscience, Inc.
• LGC Biosearch Technologies
• IBA Lifesciences GmbH
• Eurofins Scientific
• Integrated DNA Technologies, Inc.
• Quintara Biosciences
• GenScript

Segments Covered in the Report

By Service Type

• Oligonucleotide Synthesis
• Gene Synthesis

By Application

• Research & Development
• Diagnostics
• Therapeutics

By End Use

• Biopharmaceutical & Diagnostics Companies
• Academic & Research Institutes
• Contract Research Organizations (CROs)